Cite
HARVARD Citation
Michienzi, S. et al. (2019). Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis. International journal of STD & AIDS. pp. 181-187. [Online].